tiprankstipranks
Advertisement
Advertisement
Options Volatility and Implied Earnings Moves Today, July 14, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, July 14, 2026
6d ago
ANGO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ANGO Upcoming Earnings Report: What to Expect?
8d ago
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
Premium
The Fly
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
1M ago
AngioDynamics initiated with a Buy at Freedom Broker
PremiumThe FlyAngioDynamics initiated with a Buy at Freedom Broker
4M ago
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
Premium
Ratings
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
4M ago
AngioDynamics price target lowered to $16 from $18 at Canaccord
Premium
The Fly
AngioDynamics price target lowered to $16 from $18 at Canaccord
4M ago
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
PremiumThe FlyAngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
4M ago
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
Premium
The Fly
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
4M ago
AngioDynamics Targets High‑Risk Limb Ischemia With New Auryon Trial in Europe
Premium
Company Announcements
AngioDynamics Targets High‑Risk Limb Ischemia With New Auryon Trial in Europe
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100